e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Monitoring airway diseases with lung function tests
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD severity related to extended measurements of lung volume, diffusion, and resistance
L. Jarenbäck, G. Eriksson, S. Peterson, L. Bjermer, E. Tufvesson (Lund, Sweden)
Source:
International Congress 2014 – Monitoring airway diseases with lung function tests
Session:
Monitoring airway diseases with lung function tests
Session type:
Thematic Poster Session
Number:
3963
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Jarenbäck, G. Eriksson, S. Peterson, L. Bjermer, E. Tufvesson (Lund, Sweden). COPD severity related to extended measurements of lung volume, diffusion, and resistance. Eur Respir J 2014; 44: Suppl. 58, 3963
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Double-tracer gas washout in stable asthma and COPD
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Cardiac structure and function at baseline in the DEFLATA study: The impact of lung hyperinflation and its relationship with the GOLD classification
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Evaluation of the use of CAT in COPD. Results of On-Sint study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Correlation of GINA asthma control with lung volumes, airway resistance, diffusion and 6MWT
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016
Correlation among functional respiratory parameters and disease control in asthma
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
The relationship between surfactant protein D and respiratory functions in COPD
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Contribution of respiratory resistance variability measured by forced oscillation technique (FOT) to assess the likelihood of asthma diagnosis
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
COPD phenotypes according to high resolution CT scan findings
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Prevalence of small airway dysfunction among GOLD stages in COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Body-plethysmographic measurements of bronchodilator response in stable COPD
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
Impulse-oscillometry (IOS) differences in asthma and COPD patients, and healthy-subjects
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
Improved characterization of obstructive airways diseases by parameterization of specific resistance loops
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Surfactant protein expression at various COPD Gold stages
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Is early diagnosis of COPD possible? Preliminary results of early COPD study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Quantitative CT in COPD MAP: Emphysema and small airways disease independently contribute to FEV
1
Source: Annual Congress 2013 –Functional imaging
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept